×
It looks like you're using an obsolete version of internet explorer. Internet explorer is no longer supported by Microsoft since the end of 2015. We invite you to use a newer browser such as Firefox, Google Chrome or Microsoft Edge.

Become an Oncostream member and receive full access to its content!

You must be an Oncostream member to access videos without any restrictions. Register for free in one minute and access all services provided by Oncostream.You will also be able to log into Oncostream from your Facebook or twitter account by clicking on login on the top-right corner of Oncostream website.

Registration Login


Worldwide schedules comment Share
18:00
Introduction
Dr Leïla Bengrine-Lefevre
18:05
Les nouvelles recommandations St-Paul-de-Vence appliquées en vraie vie:
  • Cas clinique d’une patiente en première ligne d’un cancer de l’ovaire avancé
    Dr Fernando Bazan
     
  • Cas Clinique d’une patiente en rechute d’un cancer de l’ovaire avancé
    Dr Leïla Bengrine-Lefevre
19:05
Défauts de la recombinaison homologue (HRD):  définition et perspectives thérapeutiques
Dr Elisabeth Luporsi
19:25
La chirurgie à l’ère des PARP Inhibiteurs
Pr Chérif Akladios
19:55 Conclusion

 

Shooting date : 2021-07-12
Last update : 2021-12-23
1 comment
Join the Discussion
  • mohamed S. merci

      Please, select your files, click upload button, write your comment and click the send button. (allowed formats : images jpeg, gif, png, and PDF)
      Your browser doesn't have Flash, Silverlight or HTML5 support.


    Suggestions

    Saturday, March 22nd 2025 from 09:30am to 12:30pm (GMT+1)
    Honolulu : Friday, March 21st 2025 from 09:30pm to 12:30am (GMT+1)
    San Francisco : Friday, March 21st 2025 from 11:30pm to 02:30am (GMT+1)
    New York : Saturday, March 22nd 2025 from 02:30am to 05:30am (GMT+1)
    Buenos Aires : Saturday, March 22nd 2025 from 04:30am to 07:30am (GMT+1)
    London / Dublin : Saturday, March 22nd 2025 from 07:30am to 10:30am (GMT+1)
    Paris / Berlin : Saturday, March 22nd 2025 from 08:30am to 11:30am (GMT+1)
    Istanbul : Saturday, March 22nd 2025 from 09:30am to 12:30pm (GMT+1)
    Moscou / Dubaï : Saturday, March 22nd 2025 from 11:30am to 02:30pm (GMT+1)
    Bangkok : Saturday, March 22nd 2025 from 02:30pm to 05:30pm (GMT+1)
    Shanghai : Saturday, March 22nd 2025 from 03:30pm to 06:30pm (GMT+1)
    Tokyo : Saturday, March 22nd 2025 from 04:30pm to 07:30pm (GMT+1)
    Sydney : Saturday, March 22nd 2025 from 05:30pm to 08:30pm (GMT+1)
    Wellington : Saturday, March 22nd 2025 from 07:30pm to 10:30pm (GMT+1)

    Transpyrenean Oncogynae Symposium

    Ovarian cancer: from molecular insights to multidisciplinary strategies

    Share
    Thursday, May 22nd 2025 from 09am to 06:30pm (GMT+2)
    Honolulu : Wednesday, May 21st 2025 from 09pm to 06:30am (GMT+2)
    San Francisco : Thursday, May 22nd 2025 from 12am to 09:30am (GMT+2)
    New York : Thursday, May 22nd 2025 from 03am to 12:30pm (GMT+2)
    Buenos Aires : Thursday, May 22nd 2025 from 04am to 01:30pm (GMT+2)
    Reykjavik : Thursday, May 22nd 2025 from 07am to 04:30pm (GMT+2)
    London / Dublin : Thursday, May 22nd 2025 from 08am to 05:30pm (GMT+2)
    Paris / Berlin : Thursday, May 22nd 2025 from 09am to 06:30pm (GMT+2)
    Istanbul : Thursday, May 22nd 2025 from 10am to 07:30pm (GMT+2)
    Moscou / Dubaï : Thursday, May 22nd 2025 from 11am to 08:30pm (GMT+2)
    Bangkok : Thursday, May 22nd 2025 from 02pm to 11:30pm (GMT+2)
    Shanghai : Thursday, May 22nd 2025 from 03pm to 12:30am (GMT+2)
    Tokyo : Thursday, May 22nd 2025 from 04pm to 01:30am (GMT+2)
    Sydney : Thursday, May 22nd 2025 from 06pm to 03:30am (GMT+2)
    Wellington : Thursday, May 22nd 2025 from 08pm to 05:30am (GMT+2)

    16e congrès de la SFCO

    Rediffusion en direct

    Share
    Tuesday, September 5th 2023 from 06:30pm to 08pm (GMT+2)
    Honolulu : Tuesday, September 5th 2023 from 06:30am to 08am (GMT+2)
    San Francisco : Tuesday, September 5th 2023 from 09:30am to 11am (GMT+2)
    New York : Tuesday, September 5th 2023 from 12:30pm to 02pm (GMT+2)
    Buenos Aires : Tuesday, September 5th 2023 from 01:30pm to 03pm (GMT+2)
    Reykjavik : Tuesday, September 5th 2023 from 04:30pm to 06pm (GMT+2)
    London / Dublin : Tuesday, September 5th 2023 from 05:30pm to 07pm (GMT+2)
    Paris / Berlin : Tuesday, September 5th 2023 from 06:30pm to 08pm (GMT+2)
    Istanbul : Tuesday, September 5th 2023 from 07:30pm to 09pm (GMT+2)
    Moscou / Dubaï : Tuesday, September 5th 2023 from 08:30pm to 10pm (GMT+2)
    Bangkok : Tuesday, September 5th 2023 from 11:30pm to 01am (GMT+2)
    Shanghai : Wednesday, September 6th 2023 from 12:30am to 02am (GMT+2)
    Tokyo : Wednesday, September 6th 2023 from 01:30am to 03am (GMT+2)
    Sydney : Wednesday, September 6th 2023 from 03:30am to 05am (GMT+2)
    Wellington : Wednesday, September 6th 2023 from 05:30am to 07am (GMT+2)

    Les nouveaux enjeux de la prise en charge du cancer de l’ovaire en première ligne : L’exemple d...

    Cycle d'enseignement sur le cancer de l'ovaire - Première session

    Share
    Wednesday, March 20th 2024 from 07pm to 08pm (GMT+1)
    Honolulu : Wednesday, March 20th 2024 from 07am to 08am (GMT+1)
    San Francisco : Wednesday, March 20th 2024 from 09am to 10am (GMT+1)
    New York : Wednesday, March 20th 2024 from 12pm to 01pm (GMT+1)
    Buenos Aires : Wednesday, March 20th 2024 from 02pm to 03pm (GMT+1)
    London / Dublin : Wednesday, March 20th 2024 from 05pm to 06pm (GMT+1)
    Paris / Berlin : Wednesday, March 20th 2024 from 06pm to 07pm (GMT+1)
    Istanbul : Wednesday, March 20th 2024 from 07pm to 08pm (GMT+1)
    Moscou / Dubaï : Wednesday, March 20th 2024 from 09pm to 10pm (GMT+1)
    Bangkok : Thursday, March 21st 2024 from 12am to 01am (GMT+1)
    Shanghai : Thursday, March 21st 2024 from 01am to 02am (GMT+1)
    Tokyo : Thursday, March 21st 2024 from 02am to 03am (GMT+1)
    Sydney : Thursday, March 21st 2024 from 03am to 04am (GMT+1)
    Wellington : Thursday, March 21st 2024 from 05am to 06am (GMT+1)

    Immunothérapies et inhibiteurs de PARP dans la prise en charge du cancer de l’endomètre avancé ...

    éclairages du congrès de la SGO

    Share
    Scroll Up